Bacterial and fungal cellular components (PAMPs)

Bacterial and fungal cellular components represent a diverse group of molecular structures unique to microorganisms that serve as primary targets for antimicrobial therapy and innate immune recognition (PMC2656370). These components include the bacterial peptidoglycan cell wall, fungal ergosterol and beta-glucans, microbial ribosomes (30S and 50S subunits), and specific enzymes involved in nucleic acid synthesis or metabolic pathways like folate production (StatPearls: Antibiotics). In the context of the host immune system, these are often classified as Pathogen-Associated Molecular Patterns (PAMPs), which are recognized by Pattern Recognition Receptors (PRRs) such as Toll-like receptors (TLRs) to trigger an inflammatory response (PMC2656370). Drugs targeting these components, such as beta-lactam antibiotics or azole antifungals, exploit the biochemical differences between microbial and human cells to achieve selective toxicity (StatPearls: Antifungal Agents). However, the broad nature of this classification encompasses a wide array of distinct molecular targets, making it a functional grouping rather than a single therapeutic entity.

Other names

Pathogen-associated molecular patternsMicrobial-associated molecular patternsMAMPsMicrobial componentsBacterial cell wallFungal cell wallMicrobial ribosomesMicrobial nucleic acids

Inhibition of cell wall synthesis, disruption of cell membrane integrity, inhibition of protein synthesis, inhibition of nucleic acid synthesis, and activation of innate immune receptors (e.g., Toll-like receptors).